Abingdon Health Plc (LON:ABDX – Get Free Report) shares traded up 14.1% during mid-day trading on Monday . The company traded as high as GBX 9 ($0.11) and last traded at GBX 9 ($0.11). 107,865 shares changed hands during mid-day trading, a decline of 28% from the average session volume of 149,680 shares. The stock had previously closed at GBX 7.89 ($0.10).
Abingdon Health Trading Up 14.1 %
The company has a quick ratio of 1.96, a current ratio of 1.95 and a debt-to-equity ratio of 46.64. The company’s 50-day moving average is GBX 7.71 and its 200-day moving average is GBX 8.79. The stock has a market capitalization of £17.06 million, a price-to-earnings ratio of -899.00 and a beta of 0.13.
Abingdon Health Company Profile
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.
See Also
- Five stocks we like better than Abingdon Health
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- MP Materials: Rare Earth Elements Powering the EV Boom
- Investing in Construction Stocks
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.